Intergroupe Francophone de Cancérologie Thoracique
- Research works
- 71 ▲ 7% vs 2013–17
- Citations
- 721 10.1 per fractional work
- Top-10% rate
- 5.8% record average 16.5%
- Open access
- 27% world 28%
Not ranked overall: Intergroupe Francophone de Cancérologie Thoracique is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 3.1×. Every wedge is a field page.
- Health Professions 3.1×
- Medicine 2.9×
- Pharmacology, Toxicology and Pharmaceutics 2.1×
- Computer Science 1.5×
- Mathematics 1.4×
- Arts and Humanities 1.3×
- Immunology and Microbiology 1.2×
- Psychology 0.8×
- Biochemistry, Genetics and Molecular Biology 0.6×
- Social Sciences 0.5×
- Dentistry 0.5×
- Economics, Econometrics and Finance 0.4×
- Chemistry 0.2×
- Engineering 0.2×
- Physics and Astronomy 0.2×
- Neuroscience 0.1×
- Agricultural and Biological Sciences 0.0×
- Environmental Science 0.0×
Who are the top researchers at Intergroupe Francophone de Cancérologie Thoracique?
Ranked on the composite score, Franck Morin, Alexandra Langlais and Michèle Beau‐Faller lead among researchers whose main affiliation is Intergroupe Francophone de Cancérologie Thoracique.
- 1 Franck Morin France · #151,434 worldwide 204 citations · 70 works
- 2 Alexandra Langlais France · #157,516 worldwide 157 citations · 56 works
- 3 Michèle Beau‐Faller France · #189,903 worldwide 152 citations · 20 works
Which keywords describe research at Intergroupe Francophone de Cancérologie Thoracique?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Clinical Trials, Adjuvant Therapy, Radiotherapy, Lung Cancer, CT Screening and Tumor Staging.
- Social Innovation
- Neoadjuvant Therapy
- Quantitative Analysis
- Health Disparities
- Texture Analysis
- Population-Based Study
- Survival Analysis
- Cancer Incidence
- Healthcare Quality Indicators
- Clinical Practice Guidelines
- Precision Medicine
- Genomic Profiles
- Tumor Markers
- Prognostic Factors
- EGFR Mutations
- Genomic Profiling
- Tumor Staging
- CT Screening
- Adjuvant Therapy
- Targeted Therapy
- Chemotherapy
- Clinical Trials
- Radiotherapy
- Lung Cancer
- Treatment Guidelines
- ALK Inhibitors
- Immunotherapy
- Metastasis
- Biomarkers
- Small-Cell Lung Cancer
- Public Health
- Healthcare Policy
- Inequalities
- Medical Imaging
- Community Engagement
- Territorial Governance
- Endoscopic Resection
- Molecular Subtypes
- Radiomics
- Multilingualism
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy15▲ 31×16 topics
- Targeted Therapy12▲ 82×4 topics
- Clinical Trials12▲ 27×6 topics
- Adjuvant Therapy10▲ 123×2 topics
- Radiotherapy10▲ 36×8 topics
- CT Screening9▲ 224×1 topic
- Lung Cancer9▲ 76×2 topics
- Tumor Staging9▲ 140×1 topic
- Treatment Guidelines9▲ 58×4 topics
- Genomic Profiling9▲ 121×2 topics
- ALK Inhibitors8▲ 215×1 topic
- EGFR Mutations8▲ 215×1 topic
- Immunotherapy6▲ 13×13 topics
- Prognostic Factors6▲ 18×12 topics
- Metastasis4▲ 15×5 topics
- Tumor Markers4▲ 68×2 topics
- Biomarkers3▲ 7.4×5 topics
- Genomic Profiles3▲ 124×1 topic
- Small-Cell Lung Cancer3▲ 124×1 topic
- Precision Medicine3▲ 12×3 topics
- Public Health3▲ 2.7×5 topics
- Clinical Practice Guidelines2▲ 5.3×9 topics
- Healthcare Policy2▲ 39×1 topic
- Healthcare Quality Indicators2▲ 52×2 topics
- Inequalities2▲ 79×1 topic
- Cancer Incidence2▲ 19×3 topics
- Medical Imaging2▲ 9.3×3 topics
- Survival Analysis2▲ 9.2×5 topics
- Community Engagement2▲ 8.0×3 topics
- Population-Based Study2▲ 40×2 topics
- Territorial Governance2▲ 16×2 topics
- Texture Analysis2▲ 16×2 topics
- Endoscopic Resection2▲ 22×2 topics
- Health Disparities2▲ 10×3 topics
- Molecular Subtypes2▲ 24×2 topics
- Quantitative Analysis2▲ 13×1 topic
- Radiomics2▲ 33×1 topic
- Neoadjuvant Therapy1▲ 8.7×5 topics
- Multilingualism1▲ 13×3 topics
- Social Innovation1▲ 15×1 topic
Which research topics does Intergroupe Francophone de Cancérologie Thoracique publish most on?
By volume in 2022–2025: Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Healthcare Systems and Practices and Lung Cancer Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 3 Healthcare Systems and Practices General Health Professions 1 works
- 4 Lung Cancer Research Studies Oncology 0 works
- 5 Myasthenia Gravis and Thymoma Neurology 0 works
- 6 Caribbean history, culture, and politics Cultural Studies 0 works
- 7 Music History and Culture Music 0 works
- 8 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
- 9 Global Cancer Incidence and Screening Oncology 0 works
- 10 Migration, Health and Trauma Clinical Psychology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Intergroupe Francophone de Cancérologie Thoracique's research output changed?
Output in 2018–2022 was 7% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.